This invention provides a novel Fas antigen derivative which comprises at least a part or entire portion of Fas antigen extracellular region polypeptide in which at least one amino acid residue is deleted from a group of amino acid residues starting from the N-terminal amino acid residue of the Fas antigen polypeptide to a cysteine residue most close to the N-terminal side (excluding said cysteine residue), as well as a DNA fragment which encodes said Fas antigen derivative, a recombinant DNA molecule which contains said DNA sequence, a transformant in which said recombinant DNA molecule is introduced, a method for the production of said Fas antigen derivative, a medicament which contains said novel Fas antigen derivative as the active ingredient and a method for the improvement of activities and functions of Fas antigen and the like.

 
Web www.patentalert.com

< Isolation of neurotrophins from a mixture containing neurotrophin variants using hydrophobic interaction chromatography

< Screening methods for identifying ligands

> Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof

> Gene promoter sequences and uses thereof

~ 00213